Accelrys Inc., of San Diego, appointed William Taylor vice president of marketing.
Adventrx Pharmaceuticals Inc., of San Diego, appointed Evan Levine president and CEO.
Alfacell Corp., of Bloomfield, N.J., appointed K. Ravi Acharya to its scientific advisory board.
AspenBio Inc., of Castle Rock, Colo., appointed Irving Boime, William Thatcher, John Bealer, Janet Roser, Kevin McSweeney, Robert Hudak and Kathleen Palma to its scientific advisory board.
Australian Cancer Technology Ltd., of Sydney, Australia, appointed Alexander Cappello nonexecutive director of the company.
Barrier Therapeutics Inc., of Princeton, N.J., appointed Robert Campbell, Carl Ehmann and Charles Jacey to its board.
Cangene Corp., of Winnipeg, Manitoba, hired Michael Graham as its chief financial officer.
CeMines Inc., of Golden, Colo., appointed Mehis Pold director of research, molecular medicine.
Compugen Ltd., of Tel Aviv, Israel, appointed Noam Shani vice president of biology research and development.
Cortex Pharmaceuticals Inc., of Irvine, Calif., appointed Harry Mansbach chief medical officer and vice president, clinical development.
Cougar Biotechnology Inc., of Los Angeles, appointed Charles Eyler vice president of finance.
Diffusion Pharmaceuticals, of Charlottesville, Va., appointed Chris Dvergsten senior director of scientific affairs, and Kelly Hoy director of regulatory filings.
Ecopia BioSciences Inc., of Montreal, appointed Gregory White vice president, preclinical development.
EntreMed Inc., of Rockville, Md., promoted Carolyn Sidor to corporate vice president and chief medical officer.
InKine Pharmaceutical Co. Inc., of Blue Bell, Pa., appointed Jeffrey Arcara vice president of commercial development.
KBI BioPharma Inc., of Durham, N.C., appointed Kathy Lee vice president of quality and regulatory, Frank Bedu-Addo vice president of purification operations and biopharmaceutics, and Firoz Mistry vice president of cell culture and fermentation operations.
Kosan Biosciences Inc., of Hayward, Calif., promoted Robert Johnson to executive vice president, development and chief medical officer, and appointed Gary Palmer executive director, medical affairs.
Lorus Therapeutics Inc., of Toronto, appointed Paul Van Damme chief financial officer.
Medicago Inc., of Quebec City, appointed Pierre Labbe vice president and chief financial officer.
Merix Bioscience Inc., of Durham, N.C., appointed Lothar Finke vice president of clinical development, Doug Winship vice president of quality and regulatory affairs, and Michel Greco and Richard Meadows to its board.
Microtek Medical Holdings Inc., of Columbus, Miss., appointed Barbara Osborne executive vice president of sales and marketing.
MonoSol Rx LLC, of Portage, Ind., appointed Tushar Misra vice president of pharmaceutical operations.